SMYD3 contributes to a more aggressive phenotype of prostate cancer and targets Cyclin D2 through H4K20me3.

Oncotarget · 2015 · PMC4537039 · PMID 25980436

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Both LNCaP and PC3 cells showed a paradoxical increment in H3K4me2 and H3K4me3 as well as a decrease in H3K4me1, but these differences did not reach statistical significance.

also in 75,281 other papers

difference was apparentno p-value reported

No statistically significant difference was apparent in linear vessel density counted ex ovo between sh-scramble and sh-SMYD3 cells, for both cell lines.

also in 455 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.